Contineum Dials Back Plans with $110M IPO to Fund Neuroinflammatory Trials

Published: Apr 05, 2024 By Nick Paul Taylor

NASDAQ Market site/iStock

Pictured: Nasdaq signage and building in New York City/iStock, hapabapa

Contineum Therapeutics went public on Friday, trading on the Nasdaq Global Select Market under the ticker symbol CTNM and…
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks